Sunniva (XCNQ:SNN) Institutional Ownership : 0.03% (As of Sep. 22, 2024)

View and export this data going back to 2018. Start your Free Trial

What is Sunniva Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Sunniva's institutional ownership is 0.03%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Sunniva's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Sunniva's Float Percentage Of Total Shares Outstanding is 0.00%.

Sunniva Institutional Ownership Historical Data

The historical data trend for Sunniva's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sunniva Institutional Ownership Chart

Sunniva Historical Data

The historical data trend for Sunniva can be seen below:

	2019-08-31	2019-09-30	2019-10-31	2019-11-30	2019-12-31	2020-01-31	2020-02-29	2020-03-31	2020-04-30	2020-05-31
Institutional Ownership	0.55	0.27	0.22	0.03	0.03	0.03	0.03	0.03	0.03	0.03

Sunniva Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

Sunniva Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sunniva Inc (XCNQ:SNN) » Definitions » Institutional Ownership

Comparable Companies

Traded in Other Exchanges

N/A

Address

200 Burrard Street, 1200 Waterfront Centre, P.O Box 48600, Vancouver, BC, CAN, V7X 1T2

Website

https://www.sunniva.com

Sunniva Inc is vertically integrated medical cannabis company committed to delivering safe, low-cost, high-quality products and services at scale. The company is focused on the cultivation, production and distribution of therapeutic solutions targeting two of the medical cannabis markets in the world: Canada and California.

Executives

Mark Hamish Kimmins

Director or Senior Officer of Insider or Subsidiary (other than in 4,5,6)